The Enhancement of Female Sexual Function with ArginMax, a Nutritional Supplement, Among Women Differing in Menopausal Status

We conducted a double-blind, placebo-controlled study to determine the role of dietary supplementation on sexual function in women of differing menopausal status. One hundred eight (108) women, age 22-73 years, who reported a lack of sexual desire, enrolled as participants. Of these, 55 received Arg...

Full description

Saved in:
Bibliographic Details
Published in:Journal of sex & marital therapy 2006-12, Vol.32 (5), p.369-378
Main Authors: Ito, Thomas Y., Polan, Mary Lake, Whipple, Beverly, Trant, Aileen Sontag
Format: Article
Language:English
Subjects:
Adult
Adult and adolescent clinical studies
Affect
Aged
Biological and medical sciences
Dietary Supplements
Double-Blind Method
Female
Genital system. Reproduction
Glycosides - administration & dosage
Humans
Libido
Medical sciences
Menopause
Middle Aged
Minerals - administration & dosage
Pharmacology. Drug treatments
Plant Preparations - administration & dosage
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Sensation - drug effects
Severity of Illness Index
Sexual behavior disorders. Psychogenic sexual dysfunctions
Sexual Dysfunctions, Psychological - drug therapy
Surveys and Questionnaires
Treatment Outcome
Women's Health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We conducted a double-blind, placebo-controlled study to determine the role of dietary supplementation on sexual function in women of differing menopausal status. One hundred eight (108) women, age 22-73 years, who reported a lack of sexual desire, enrolled as participants. Of these, 55 received ArginMax for women and 53 received placebo. ArginMax for women contains L-arginine, ginseng, ginkgo, damiana, multivitamins, and minerals. The 108 women, given definitions, self-reported as 59 premenopausal (PRE); 20 perimenopausal (PERI), and 29 postmenopausal (POST). After 4 weeks, PRE women on ArginMax primarily reported significant improvement in level of sexual desire (72%; p = 0.03) and satisfaction with overall sex life (68%; p = 0.007), compared with placebo group, according to the Female Sexual Function Index (FSFI; Kaplan et al., 1999 ) scales. Frequency of sexual desire (60%; p = 0.05) and frequency of intercourse (56% p = 0.01) also increased among the PRE women. In contrast, among PERI women, primary improvements were reported for frequency of intercourse (86%; p = 0.002), satisfaction with sexual relationship (79%; p = 0.03), and vaginal dryness (64%; p = 0.03) compared with placebo group. POST women primarily showed an increased in level of sexual desire, with 51% showing improvement, compared with only 8% in the placebo group (p = 0.008). Nutritional intervention plays an important role in women's sexual health, but issues and areas of greatest improvement differ among women of different menopausal states. The largest number of attribute improvements were seen in PRE and PERI women, although attribute types vary among these groups. Level of desire was shown to increase significantly in POST women. Since ArginMax for women has been shown to exhibit no estrogen activity, it may be desirable alternative to hormone therapy for sexual concerns.
ISSN:0092-623X
1521-0715
DOI:10.1080/00926230600834901